TY - JOUR
T1 - Patient perception of telehealth services for breast and gynecologic oncology care during the covid-19 pandemic
T2 - A single center survey-based study
AU - Zimmerman, Brittney S.
AU - Seidman, Danielle
AU - Berger, Natalie
AU - Cascetta, Krystal P.
AU - Nezolosky, Michelle
AU - Trlica, Kara
AU - Ryncarz, Alisa
AU - Keeton, Caitlin
AU - Moshier, Erin
AU - Tiersten, Amy
N1 - Funding Information:
The authors wish to acknowledge the support of the Biostatistics Shared Resource Facility funded by the National Cancer Institute Cancer Center Support Grant P30CA196521-01 for analysis and interpretation of data and preparation of the manuscript.
Publisher Copyright:
© 2020 Korean Breast Cancer Society.
PY - 2020/10
Y1 - 2020/10
N2 - Prior to the coronavirus disease 2019 (COVID-19) pandemic, telehealth was rarely utilized for oncologic care in metropolitan areas. Our large New York City based outpatient breast/ gynecologic cancer clinic administered an 18-question survey to patients from March to June 2020, to assess the perceptions of the utility of telehealth medicine. Of the 622 patients, 215 (35%) completed the survey, and of the 215 respondents, 74 (35%) had participated in a telehealth visit. We evaluated the use of telehealth services using the validated Service User Technology Acceptability Questionnaire. Sixty-eight patients (92%) reported that telehealth services saved them time, 54 (73%) reported telehealth increased access to care, and 58 (82%) reported telehealth improved their health. Overall, 67 (92%) of patients expressed satisfaction with the use of telehealth services for oncologic care during the COVID-19 pandemic. Telehealth services should be carefully adopted as an addition to in-person clinical care of patients with cancer.
AB - Prior to the coronavirus disease 2019 (COVID-19) pandemic, telehealth was rarely utilized for oncologic care in metropolitan areas. Our large New York City based outpatient breast/ gynecologic cancer clinic administered an 18-question survey to patients from March to June 2020, to assess the perceptions of the utility of telehealth medicine. Of the 622 patients, 215 (35%) completed the survey, and of the 215 respondents, 74 (35%) had participated in a telehealth visit. We evaluated the use of telehealth services using the validated Service User Technology Acceptability Questionnaire. Sixty-eight patients (92%) reported that telehealth services saved them time, 54 (73%) reported telehealth increased access to care, and 58 (82%) reported telehealth improved their health. Overall, 67 (92%) of patients expressed satisfaction with the use of telehealth services for oncologic care during the COVID-19 pandemic. Telehealth services should be carefully adopted as an addition to in-person clinical care of patients with cancer.
KW - Breast neoplasms
KW - Coronavirus
KW - Quality of life
KW - Telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85094649854&partnerID=8YFLogxK
U2 - 10.4048/jbc.2020.23.e56
DO - 10.4048/jbc.2020.23.e56
M3 - Article
AN - SCOPUS:85094649854
SN - 1738-6756
VL - 23
SP - 542
EP - 552
JO - Journal of Breast Cancer
JF - Journal of Breast Cancer
IS - 5
ER -